Table 2 Incidence and time of occurrence of the different categories of hyperglycemia at 8 weeks follow-up in all studied patients (n = 32)

Non-hyperglycemic (≤ 5.6 mmol/L)

n (%)

10 (31.3)

Baseline fasting glycemia (mmol/L)

4.7 ± 0.6

Plasma glucose (mmol/L)

4.5 ± 0.8

Cyclic

10

Continuous

0

PAD (mg/patient)¹

1500 ± 0

Fasting hyperglycemia (≥5.60 mmol/L)

Incidence, n (%)

22 (68.7)

Baseline fasting glycemia (mmol/L)

4.8 ± 0.7

Plasma glucose (mmol/L)

7.08 ± 3.04

PAD (mg/patient)²

2972 ± 1376

Cyclic

10

Continuous

12

P value (1 vs. 2)

0.002*

Prediabetes (≥5.60- < 7.00 mmol/L)

Incidence, n (%)

11 (34.3)

Baseline fasting glycemia (mmol/L)

4.6 ± 0.9

Plasma glucose (mmol/L)³

6.01 ± 0.35

PAD (mg/patient)³

2727 ± 1410

P value (1 vs. 3)

0.01*

Prediabetes appearance (week), n (%)

First

6 (54.5)

Second to fourth

2 (18.1)

Fifth to eighth

3 (27.3)

DM (fasting glycemia ≥7.00 mmol/L)

Incidence, n (%)

11 (34.3)

Baseline fasting glycemia (mmol/L)

5.1 ± 0.8

Plasma glucose (mmol/L)

8.90 ± 3.63

PAD (mg/patient) ⁴

3218 ± 1362

P value (1 vs. 4)

0.0008*

P value (3 vs. 4)

0.67

DM occurrence (week), n (%)

First

0 (0)

Second to fourth

5 (45.5)

Fifth to eighth

6 (54.5)

Postprandial hyperglycemia

Incidence, n^† (%)

5 (15.6)

Capillary Glycemia (mmol/L)

11.33 ± 0.30

PAD (mg/patient)

Hyperglycemic cases⁵

2040 ± 1207

Non-hyperglycemic cases⁶

2600 ± 1351

P value (5 vs. 6)

0.39